Antonio E. Civitarese

Clinical Drug Combination Program Head, Clinical Research & Development at Intercept Pharmaceuticals

Antonio E. Civitarese has a rich and diverse work experience. Antonio E. is currently the Founder and President of CIV MedSciences, LLC, which they established in 2023. Before this, they held various roles at Intercept Pharmaceuticals, including Clinical Drug Combination Program Head and Vice President. Antonio E. also co-founded Awaken Health MD in 2019. In 2016, they founded Elite Bio Nutrition and served as its Founder until early 2019. Antonio has also held positions such as Director of Medical Affairs at La Jolla Pharmaceutical Company and Scientific Director Metabolic Diseases at Novo Nordisk. Additionally, they have co-founded BioShore Partners, Inc. and served as its Partner, where they focused on assembling drug portfolio opportunities to address metabolic and skeletal muscle indications. Antonio E. founded Exergy BioPharma L.L.C in 2011 and served as its Founder until 2014. Prior to that, they were the Director of Skeletal Muscle Metabolism at Pennington Biomedical Research Center. Antonio's earlier career includes being a Senior Investigator at Amylin Pharmaceuticals. Overall, Antonio E. Civitarese has had an impressive career, showcasing their leadership, entrepreneurial skills, and expertise in the pharmaceutical and medical research industry.

Antonio E. Civitarese has a strong education background in biotechnology and molecular physiology, with a particular focus on metabolic disease, obesity, and type 2 diabetes. From 1995 to 1999, they attended Deakin University, where they obtained both a Master's and Bachelor's degree in Molecular Biotechnology. Antonio E. then pursued further studies at Deakin University and completed their PhD from 1999 to 2002 in the field of biotechnology and molecular physiology, with a double degree specialization in metabolic disease. In 2009, Antonio briefly attended Rutgers University, participating in a Minor MBA Program with a focus on BioPharma Innovation. Lastly, no specific start or end years are provided for their time at Redden College, and no degree or field of study is mentioned.

Links

Peers

View in org chart

Timeline

  • Clinical Drug Combination Program Head, Clinical Research & Development

    January, 2021 - present

  • Vice President Executive Director Sr Director Director Of Clinical Research And Development

    September, 2018

A panel showing how The Org can help with contacting the right person.